Marshall Wace North America L.P. - INTERSECT ENT INC ownership

INTERSECT ENT INC's ticker is XENT and the CUSIP is 46071F103. A total of 113 filers reported holding INTERSECT ENT INC in Q4 2020. The put-call ratio across all filers is 0.67 and the average weighting 0.1%.

Quarter-by-quarter ownership
Marshall Wace North America L.P. ownership history of INTERSECT ENT INC
ValueSharesWeighting
Q4 2020$201,000
+458.3%
8,756
+686.0%
0.00%
Q1 2019$36,000
-87.6%
1,114
-89.2%
0.00%
-100.0%
Q4 2018$290,000
-39.3%
10,278
-19.5%
0.00%0.0%
Q2 2018$478,000
+66.6%
12,760
+43.6%
0.00%
+50.0%
Q4 2017$287,000
-51.4%
8,885
-74.4%
0.00%
-60.0%
Q1 2017$590,00034,7150.01%
Other shareholders
INTERSECT ENT INC shareholders Q4 2020
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 1,332,773$27,828,0005.75%
First Light Asset Management, LLC 2,036,645$42,525,0002.82%
Altium Capital Management LP 141,856$2,962,0000.82%
PURA VIDA INVESTMENTS, LLC 909,660$18,994,0000.54%
Rock Springs Capital Management LP 1,080,200$22,555,0000.49%
Novo Holdings A/S 508,922$10,626,0000.44%
Davide Leone & Partners Investment Co Ltd. 109,240$2,281,0000.28%
PURA VIDA INVESTMENTS, LLC 256,800$5,362,0000.15%
Bellevue Group AG 617,968$12,903,0000.14%
Gyon Technologies Capital Management, LP 13,318$278,0000.12%
View complete list of INTERSECT ENT INC shareholders